Overview

Clinical Management of Neuropathic Pain With Ramelteon

Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This proposal is to conduct a double-blinded, randomized, placebo-controlled, crossover clinical study to examine the hypothesis that ramelteon would reduce pain score and improve functional status in subjects with neuropathic pain.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Takeda Pharmaceuticals North America, Inc.